The genetics of drug-related movement disorders (DRMD), reply to comment: Antipsychotic-induced catatonia and neuroleptic malignant syndrome: The dark side of the moon

被引:0
|
作者
van der Burg, Nadine C. [1 ]
Al Hadithy, Asmar F. Y. [2 ]
van Harten, Peter N. [1 ,3 ]
van Os, Jim [3 ,4 ,5 ]
Bakker, P. Roberto [3 ,4 ,6 ]
机构
[1] GGZ Centraal, Zon & Schild, Amersfoort, Netherlands
[2] Scheldezoom Pharm, S Gravenpolder, Netherlands
[3] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands
[4] Utrecht Univ Med Ctr, Brain Ctr Rudolf Magnus, Dept Psychiat, Utrecht, Netherlands
[5] Kings Coll London, Kings Hlth Partners Dept Psychosis Studies, London, England
[6] Arkin, Psychiat, Amsterdam, Netherlands
关键词
D O I
10.1038/s41380-021-01212-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:6115 / 6115
页数:1
相关论文
共 4 条
  • [1] The genetics of drug-related movement disorders (DRMD), reply to comment: Antipsychotic-induced catatonia and neuroleptic malignant syndrome: The dark side of the moon
    Nadine C. van der Burg
    Asmar F. Y. Al Hadithy
    Peter N. van Harten
    Jim van Os
    P. Roberto Bakker
    Molecular Psychiatry, 2021, 26 : 6115 - 6115
  • [2] Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon
    Hirjak, Dusan
    Sartorius, Alexander
    Kubera, Katharina M.
    Wolf, Robert Christian
    MOLECULAR PSYCHIATRY, 2021, 26 (11) : 6112 - 6114
  • [3] Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon
    Dusan Hirjak
    Alexander Sartorius
    Katharina M. Kubera
    Robert Christian Wolf
    Molecular Psychiatry, 2021, 26 : 6112 - 6114
  • [4] What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review
    Virolle, Jordan
    Redon, Maximilien
    Montastruc, Francois
    Taib, Simon
    Revet, Alexis
    Zivkovic, Vuk
    Da Costa, Julien
    Very, Etienne
    SCHIZOPHRENIA RESEARCH, 2023, 262 : 184 - 200